Meropenem-resistant Burkholderia pseudomallei: a concerning single case in Australia with no prior meropenem exposure
2024

Meropenem-resistant Burkholderia pseudomallei case in Australia

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Sivabalan Pirathaban, Satyaputra Ferris, Gassiep Ian, Forde Brian, Frazer Jaimie, Glover Matthew, Adams Buenafe, Norton Robert

Primary Institution: Pathology Queensland, Townsville Hospital, Douglas, Townsville, Queensland, Australia

Hypothesis

Is there a meropenem-resistant sub-population of Burkholderia pseudomallei in a patient with no prior exposure to meropenem?

Conclusion

This case reports the first instance of a meropenem-resistant Burkholderia pseudomallei isolate in Australia without prior carbapenem exposure.

Supporting Evidence

  • The isolate was confirmed as Burkholderia pseudomallei through molecular detection.
  • Antimicrobial susceptibility testing revealed a meropenem MIC of >32 µg/ml for the resistant isolate.
  • This is the first reported case in Australia of a B. pseudomallei isolate resistant to meropenem without previous exposure.
  • Whole-genome sequencing did not reveal any known resistance determinants for meropenem.

Takeaway

A man in Australia got a skin infection from a germ that usually can be treated with a strong medicine called meropenem, but this germ didn't respond to it, even though he had never taken that medicine before.

Methodology

The case involved whole-genome sequencing and antimicrobial susceptibility testing of the isolate.

Limitations

The study did not completely exclude the possibility of resistance developing in vitro during susceptibility testing.

Participant Demographics

54-year-old male with type II diabetes and chronic kidney disease.

Digital Object Identifier (DOI)

10.1099/acmi.0.000619.v4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication